| Document Date: 2014-08-21 11:51:11
Open Document File Size: 164,89 KBShare Result on Facebook
IndustryTerm stroke prevention / chemical entities / combination product / chemical entity / preferred products / / MedicalCondition Physician Therapy Chronic migraines / dystonia Severe primary axillary hyperhidrosis Strabismus Cerebral Palsy / acyanotic congenital heart disease / BPH / cardiomyopathy / COPD / HIV / nonvalvular atrial fibrillation / congenital abnormalities / Item Hepatitis C / erectile dysfunction / stroke / Cirrhosis / Diabetes / Hepatitis C / Juvisync™ Hepatitis C / deep vein thrombosis / chronic lung disease / Interferons Hepatitis C / non-small cell lung cancer / benign prostatic hyperplasia / infection / Ribavirins Hepatitis C / anaplastic lymphoma kinase / chronic corticosteroids / HCV-RNA / severe pulmonary hypertension / Interferons Clinical Criteria Hepatitis C / asthma / HCV RNA / / MedicalTreatment Occupational Therapy / bypass surgery / hip surgery / knee replacement surgery / / Organization FDA / Kentucky Department / P&T Advisory Committee / / Position Physician / controller / / Product Topiramate / Synagis / theophylline / metronidazole / ibuprofen / famotidine / ribavirin / Epinephrine / Cialis / peginterferon / albuterol / Xolair / tobramycin / / ProvinceOrState Pennsylvania / / Technology alpha / genotype / /
SocialTag |
Kentucky Department for Medicaid Services Drug Review Options The following chart lists the agenda items scheduled and the options submitted for review at the January 19, 2012 meeting of the Pharmacy and Therapeutics Adv